Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38,512,859
-
Total 13F shares
-
22,625,730
-
Share change
-
-1,375,652
-
Total reported value
-
$16,969,353
-
Price per share
-
$0.75
-
Number of holders
-
34
-
Value change
-
-$2,129,242
-
Number of buys
-
16
-
Number of sells
-
12
Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q2 2024
As of 30 Jun 2024,
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,625,730 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, Vivo Capital, LLC, Sofinnova Investments, Inc., CITADEL ADVISORS LLC, Pivotal bioVenture Partners Investment Advisor LLC, Newtyn Management, LLC, Nan Fung Group Holdings Ltd, VANGUARD GROUP INC, Samsara BioCapital, LLC, and Board of Trustees of The Leland Stanford Junior University.
This page lists
34
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.